How a US-imposed tariff on Irish pharma exports might work - a theoretical risk analysis, and action plan
There are potential risks to Irish corporate tax revenues from US statements about tariffs and a 15% US corporation tax rate - examined in the November issue of Finance Dublin but, as we comment, positive and enlightened engagement on the part of the new Irish Government, and “Ireland Inc”, can turn perceived difficulty in effect into opportunity.
A quotation attributed to one time US Trade Secretary Wilbur Ross about tariffs, a first term President Trump Cabinet-appointee (see the November issue) provides an insight as to the possible strategy ‘Ireland Inc’, and the incoming Government should follow in engaging with the new US Administration on trade matters coming up. Carol Lynch, Partner, Customs and International Trade, BDO comments, and provides a risk analysis for potentially affected Irish companies.

To continue, please log in


 
 

The Latest Issue
December 2024 Issue of Finance Dublin

Order a subscription to Finance Dublin


Take out a subscription - I would like to take out a subscription, enabling me to gain immediate access to the site and this month's edition. For details on pricing options and subscription benefits please click here.

Without your explicit permission FinanceDublin.com will never share any of your information (including your e-mail address). Your information is collected in accordance with our Privacy Policy.

If you have any questions, please contact us.


Carol Lynch is partner, Customs and International Trade, at BDO.
This article appeared in the December 2024 edition.